Cell line Core
细胞系核心
基本信息
- 批准号:10468635
- 负责人:
- 金额:$ 15.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AliquotAllelesBiological AssayCRISPR/Cas technologyCell LineCellsClone CellsClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunitiesCredentialingCryopreservationCustomDNA Double Strand BreakDNA Repair EnzymesDNA-Directed DNA PolymeraseDoxycyclineEngineeringEnsureEnzymesExperimental DesignsFutureGene TargetingGenerationsGenesGenetic EngineeringGenomeGenome engineeringGenomic InstabilityGenomicsGenotypeGoalsHumanIn VitroKaryotypeKaryotype determination procedureKnock-inKnock-outLigandsMalignant NeoplasmsMammalian CellManuscriptsMediatingMethodsModelingMonitorMusMycoplasmaPolymeraseProcessProteinsProtocols documentationPublicationsQuality ControlReagentReproducibilityResearchResearch ActivityResearch PersonnelRoleSecureServicesStandardizationStructure of thyroid parafollicular cellSystemTestingTimeTransgenesValidationbasecost effectivenessdesigndigitalempoweredexperimental studygenetically modified cellshomologous recombinationin vivointerestlaboratory experimentmultidisciplinaryoverexpressionparityprogramsprotein expressionquality assurancerepairedrepositoryscreeningservice programssuccesssynergismtranscriptome sequencingtransgene deliverytransgene expressionvector
项目摘要
PROJECT SUMMARY
This project will investigate mammalian DNA polymerase θ (Pol θ), the defining enzyme for repair of DNA
double-strand breaks by polymerase theta-mediated end joining (TMEJ). This is Core C (“Cell Line
Engineering Core”) which is part of a Program Project titled, “Polymerase theta, genome instability, and
cancer”. Core C will be responsible for providing native and genetically engineered cell lines to support all of
the cell-based assays performed in Projects 1, 2, and 4 of the Program Project.
The authentication of mammalian cell line reagents is vital for rigor and reproducibility of laboratory
experiments. By establishing and implementing standardized protocols for cell line validation, efficient genome
manipulation, cryopreservation, and dissemination, the Core will ensure quality control of cell line reagents and
minimize the likelihood of erroneous observations and interpretations.
In Aim 1, “Credentialing of mammalian cell line models utilized in this Program Project”, we will implement
a standardized and comprehensive protocol for authentication and characterization of mammalian cell line
models used across the Program Project.
In Aim 2, “CRISPR-based cell line genome engineering services for the Program Project”, we will provide
expert services in the design and execution of customized cell line genome engineering tasks in support of
Program Project goals. Cas9 protein utilized in this Aim will be provided by Core B.
In Aim 3, “Controlled and stable expression of transgenes in mammalian cell lines”, we will utilize
doxycycline-inducible and constitutive transposon vectors for the generation of cell lines that express a variety
of mutagenized and/or tagged transgenes of interest.
Core C services will be highly coordinated within the Program Project, and will facilitate rigor and
reproducibility, as well as cost-effectiveness, of highly integrated research activities aimed at understanding the
role and targetability of DNA Polymerase q in cancer.
项目概要
该项目将研究哺乳动物 DNA 聚合酶 θ (Pol θ),它是 DNA 修复的定义酶
聚合酶 theta 介导的末端连接 (TMEJ) 导致双链断裂。这是核心 C(“细胞系
工程核心”)是名为“聚合酶 theta、基因组不稳定性和
Core C 将负责提供天然和基因工程细胞系来支持所有
该计划项目的项目 1、2 和 4 中进行的基于细胞的测定。
哺乳动物细胞系试剂的认证对于实验室的严谨性和可重复性至关重要
实验。通过建立和实施细胞系验证的标准化协议,高效的基因组
操作、冷冻保存和传播,核心将确保细胞系试剂和的质量控制
最大限度地减少错误观察和解释的可能性。
在目标 1“本计划项目中使用的哺乳动物细胞系模型的认证”中,我们将实施
用于哺乳动物细胞系认证和表征的标准化和综合方案
整个计划项目中使用的模型。
在目标2“项目项目基于CRISPR的细胞系基因组工程服务”中,我们将提供
设计和执行定制细胞系基因组工程任务的专家服务,以支持
计划 项目目标。该目标中使用的 Cas9 蛋白将由 Core B 提供。
在目标 3“哺乳动物细胞系中转基因的受控和稳定表达”中,我们将利用
多西环素诱导型和组成型转座子载体,用于生成表达多种表达的细胞系
感兴趣的诱变和/或标记转基因。
核心 C 服务将在计划项目内高度协调,并将促进严谨和
高度综合的研究活动的可重复性和成本效益,旨在了解
DNA 聚合酶 q 在癌症中的作用和靶向性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gaorav P Gupta其他文献
Gaorav P Gupta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gaorav P Gupta', 18)}}的其他基金
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis
乳腺癌发病机制中 Mre11 依赖性 DNA 损伤反应
- 批准号:
10296655 - 财政年份:2018
- 资助金额:
$ 15.58万 - 项目类别:
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis
乳腺癌发病机制中 Mre11 依赖性 DNA 损伤反应
- 批准号:
10064081 - 财政年份:2018
- 资助金额:
$ 15.58万 - 项目类别:
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis
乳腺癌发病机制中 Mre11 依赖性 DNA 损伤反应
- 批准号:
10531538 - 财政年份:2018
- 资助金额:
$ 15.58万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 15.58万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 15.58万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 15.58万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 15.58万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 15.58万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 15.58万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 15.58万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 15.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 15.58万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 15.58万 - 项目类别: